The landscape of malignancy treatment is constantly evolving, with a growing emphasis on identifying novel therapeutic targets for drug creation. Traditional therapies often attack rapidly dividing cells, leading to significant side outcomes. However, the emergence of sophisticated genomic profiling techniques has revolutionized our knowledge of tu